Trial · NCT02174627
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Hb Averaged Over Week 28 to Week 52 | Roxadustat | 1.75 | Standard Error 0.033 | g/dL | |
| Mean Change From Baseline in Hb Averaged Over Week 28 to Week 52 | Placebo | 0.40 | Standard Error 0.034 | g/dL | |
| Percentage of Participants With Hb Response During the First 24 Weeks of Treatment | Roxadustat | 77.0 | Percentage of participants | ||
| Percentage of Participants With Hb Response During the First 24 Weeks of Treatment | Placebo | 8.5 | Percentage of participants | ||
| Mean Change From Baseline in Hb Averaged Over Week 28 to Week 52 in Participants With Baseline High Sensitivity C-Reactive Protein (hsCRP) Greater Than the Upper Limit of Normal (ULN) | Roxadustat | 1.75 | Standard Error 0.087 | g/dL | |
| Mean Change From Baseline in Hb Averaged Over Week 28 to Week 52 in Participants With Baseline High Sensitivity C-Reactive Protein (hsCRP) Greater Than the Upper Limit of Normal (ULN) | Placebo | 0.62 | Standard Error 0.091 | g/dL | |
| Proportion of Total Time of Interpolated Hb Values Greater Than or Equal To 10 g/dL From Week 28 to Week 52 | Roxadustat | 0.82 | Standard Error 0.011 | proportion of total time | |
| Proportion of Total Time of Interpolated Hb Values Greater Than or Equal To 10 g/dL From Week 28 to Week 52 | Placebo | 0.33 | Standard Error 0.011 | proportion of total time | |
| Proportion of Total Time of Interpolated Hb Values Within the Interval of 10 to 12 g/dL From Week 28 to Week 52 | Roxadustat | 0.70 | Standard Error 0.010 | proportion of total time | |
| Proportion of Total Time of Interpolated Hb Values Within the Interval of 10 to 12 g/dL From Week 28 to Week 52 | Placebo | 0.28 | Standard Error 0.010 | proportion of total time | |
| Mean Change in Low-Density Lipoprotein (LDL) Cholesterol From Baseline to Week 24 | Roxadustat | -0.38 | Standard Error 0.028 | millimole per liter | |
| Mean Change in Low-Density Lipoprotein (LDL) Cholesterol From Baseline to Week 24 | Placebo | -0.02 | Standard Error 0.027 | millimole per liter | |
| Time-To-First Instance of Receiving IV Iron, RBC Transfusion or Erythropoietin Analogue as Rescue Therapy | Roxadustat | 11.90 | Events per 100 participant years | ||
| Time-To-First Instance of Receiving IV Iron, RBC Transfusion or Erythropoietin Analogue as Rescue Therapy | Placebo | 39.76 | Events per 100 participant years | ||
| Time-To-First Instance of Receiving a RBC Transfusion As Rescue Therapy | Roxadustat | 7.98 | Events per 100 participant years | ||
| Time-To-First Instance of Receiving a RBC Transfusion As Rescue Therapy | Placebo | 19.61 | Events per 100 participant years | ||
| Mean Change From Baseline in Short Form 36 (SF-36) Vitality Sub-Score From Week 12 to Week 28 | Roxadustat | 1.59 | Standard Error 0.231 | scores on a scale | |
| Mean Change From Baseline in Short Form 36 (SF-36) Vitality Sub-Score From Week 12 to Week 28 | Placebo | 1.15 | Standard Error 0.233 | scores on a scale | |
| Annual Rate of eGFR Change From Baseline Prior to the Initiation of Dialysis or Kidney Transplant | Roxadustat | -3.70 | eGFR rate (mL/min/1.73m^2/years) | ||
| Annual Rate of eGFR Change From Baseline Prior to the Initiation of Dialysis or Kidney Transplant | Placebo | -3.19 | eGFR rate (mL/min/1.73m^2/years) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02174627/results